Regeneron Pharmaceuticals, Inc. (0R2M.L) LSE

575.75

+6.78(+1.19%)

Updated at September 08 01:40PM

Currency In USD

Valuation

Market Cap76.86B
Enterprise Value77.08B
P/E Ratio13.52
PEG Ratio-564.43
Price/Sales Ratio4.2
Price/Book Ratio2.01
Enterprise/Revenue4.25
Enterprise/EBITDA11.15

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.31
Operating Margin0.28

Management Effectiveness

Return On Assets0.12
Return On Equity0.15

Income Statement

Revenue14.2B
Revenue/Share135.24
Gross Profit11.75B
EBITDA5.32B
Net Income4.41B
Diluted EPS38.34

Balance Sheet

Total Cash7.47B
Total Cash/Share71.07
Total Debt2.71B
Total Debt/Equity0.09
Current Ratio4.6
Book Value Per Share284.86

Price History

52-Week Change-50.5
52-Week High998.57
52-Week Low563.95
Moving Average 50 Days947.92
Moving Average 200 Days834.06

Statistics

Average Volume1,962
Shares Outstanding104.17M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate2.64
Trailing Annual Dividend Yield0.46
Payout Ratio0.04
Last Split FactorN/A
Last Split DateN/A